PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 8038 (117th)

Formula Shortage Reporting Act of 2022

referredUnited States· United States Congress· EN

Introduced

13 June 2022

Last action

13 June 2022 · Introduced

Status

Referred to the House Committee on Energy and Commerce.

Sponsors

Dusty Johnson, Abigail Spanberger, Stephanie Bice, Kim Schrier

Subjects

Healthcare

Source updated

3 January 2025

Healthcare

Summary

Formula Shortage Reporting Act of 2022 This bill requires manufacturers of infant formula to notify the Food and Drug Administration (FDA) at least 72 hours in advance of a manufacturing interruption or product discontinuance that is expected to meaningfully disrupt the product's supply. The FDA must post such information on its website and notify health care providers.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 13 June 2022

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 13 June 2022

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 13 June 2022

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.